JINS HOLDINGS Inc. (JP:3046)
:3046
Want to see JP:3046 full AI Analyst Report?
Top Page
JINS HOLDINGS
(3046)
Select Model
Select Model
Rating:78Outperform
Price Target:
¥8,265.00
▲(33.31% Upside)
Action:Upgraded
Date:05/13/26
The score is driven primarily by strong financial performance (improving profitability and solid cash generation) and supportive technical momentum. These positives are moderated by overbought technical conditions (RSI ~74) and only modest dividend support.
Positive Factors
Strong free cash flow generation
Consistent free cash flow growth and efficient conversion of earnings into cash provide durable funding for store investment, inventory and technology, reduce reliance on external financing, and support the firm's ability to pay down debt or fund strategic initiatives over the next several quarters.
Negative Factors
Moderate reliance on debt
Although leverage is declining, the firm's moderate equity ratio implies continued dependence on debt financing. This reduces flexibility in adverse scenarios, raises interest expense sensitivity, and could constrain capital allocation if consumer demand weakens or rates rise materially.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong free cash flow generation
Consistent free cash flow growth and efficient conversion of earnings into cash provide durable funding for store investment, inventory and technology, reduce reliance on external financing, and support the firm's ability to pay down debt or fund strategic initiatives over the next several quarters.
Read all positive factors
JINS HOLDINGS (3046) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥186.49B
Dividend Yield1.97%
Average Volume (3M)219.61K
Price to Earnings (P/E)24.3
Beta (1Y)0.44
Revenue Growth14.57%
EPS Growth15.03%
CountryJP
Employees3,485
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)356.89
Shares Outstanding23,980,000
10 Day Avg. Volume250,300
30 Day Avg. Volume219,606
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)5.90
Price to Sales (P/S)1.93
P/FCF Ratio21.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)359.78
Revenue Forecast (FY)¥109.51B
JINS HOLDINGS Business Overview & Revenue Model
Company Description
JINS HOLDINGS Inc., through its subsidiaries, engages in the planning, production, distribution, and sale of eyewear and fashion accessories in Japan. It offers eyewear, such as eye glasses and lenses; and JINS MEME that enables visualization of t...
How the Company Makes Money
The company generates revenue primarily from retail sales of eyewear to end customers. Key revenue streams include: (1) prescription eyeglasses—frames and prescription lenses sold as a set or bundled offering; (2) non-prescription products such as...
JINS HOLDINGS Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 97.22B | 83.00B | 73.26B | 66.90B | 63.90B |
| Gross Profit | 72.89B | 61.55B | 53.34B | 49.18B | 47.72B |
| EBITDA | 15.04B | 10.76B | 7.76B | 6.27B | 7.75B |
| Net Income | 8.33B | 4.67B | 1.76B | 750.00M | 3.29B |
Balance Sheet | |||||
| Total Assets | 58.41B | 54.53B | 45.24B | 54.95B | 53.01B |
| Cash, Cash Equivalents and Short-Term Investments | 11.98B | 18.67B | 12.20B | 21.43B | 23.21B |
| Total Debt | 8.28B | 12.37B | 12.99B | 23.57B | 24.25B |
| Total Liabilities | 26.66B | 28.94B | 23.46B | 34.54B | 32.78B |
| Stockholders Equity | 31.74B | 25.59B | 21.78B | 20.41B | 20.22B |
Cash Flow | |||||
| Free Cash Flow | 8.53B | 9.10B | 3.14B | 1.73B | 3.47B |
| Operating Cash Flow | 10.53B | 10.99B | 6.05B | 4.39B | 5.06B |
| Investing Cash Flow | -7.86B | -2.38B | -3.85B | -3.85B | -3.17B |
| Financing Cash Flow | -9.43B | -2.33B | -11.50B | -2.77B | -3.76B |
JINS HOLDINGS Technical Analysis
Positive
6200.00
Price Trends
6340.20
Positive
5774.75
Positive
6664.85
Positive
Market Momentum
445.79
Negative
69.20
Neutral
89.21
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3046, the sentiment is Positive. The current price of 6200 is below the 20-day moving average (MA) of 7326.00, below the 50-day MA of 6340.20, and below the 200-day MA of 6664.85, indicating a bullish trend. The MACD of 445.79 indicates Negative momentum. The RSI at 69.20 is Neutral, neither overbought nor oversold. The STOCH value of 89.21 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3046.
JINS HOLDINGS Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥9.01T | 36.02 | 25.14% | 1.01% | 9.44% | 28.08% | |
78 Outperform | ¥186.49B | 24.29 | 27.95% | 1.97% | 14.57% | 15.03% | |
78 Outperform | ¥51.14B | 13.34 | ― | 3.22% | 11.84% | -5.68% | |
77 Outperform | ¥6.50B | 13.09 | ― | 2.95% | 7.03% | 5.38% | |
54 Neutral | ¥124.56B | 21.36 | 7.81% | 1.78% | 3.39% | 7.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥15.28B | 13.32 | ― | 2.65% | 2.14% | 3.96% |
* Healthcare Sector Average
JP:3046
JINS HOLDINGS
8,260.00
-121.79
-1.45%
JP:7741
HOYA
27,080.00
10,154.05
59.99%
JP:7780
Menicon Co
1,624.00
553.10
51.65%
JP:5889
Japan Eyewear Holdings Co.,Ltd.
2,092.00
-178.67
-7.87%
JP:7743
Seed Co., Ltd.
500.00
71.54
16.70%
JP:9340
ASO INTERNATIONAL INC.
664.00
123.06
22.75%
JINS HOLDINGS Corporate Events
JINS HOLDINGS Posts Strong April Sales and Opens Flagship Shinjuku Store
May 8, 2026
JINS HOLDINGS reported strong April 2026 performance at its Japanese eyewear stores, with all-store sales up 18.2% year on year and existing-store sales rising 10.5%. The gains were driven by higher average spend per customer, effective promotiona...
JINS to Take Direct Control of Philippine Eyewear Operations with Suyen Deal
Apr 24, 2026
JINS HOLDINGS will convert its JINS-branded franchise operations in the Philippines into a directly managed business by having its wholly owned subsidiary, JINS Philippines Inc., acquire Suyen Corporation’s local eyewear retail operations. T...
JINS Lowers Full-Year Forecast After Domestic Eyewear Miss, Overseas Operations Cushion Impact
Apr 10, 2026
JINS HOLDINGS reported that its consolidated results for the six months ended February 28, 2026, fell short of prior forecasts, with net sales, operating profit, ordinary profit, and profit attributable to owners of parent all coming in modestly b...
JINS HOLDINGS Grows Sales but Interim Profit Slips, Raises Full-Year Outlook
Apr 10, 2026
JINS HOLDINGS reported consolidated net sales of ¥50.5 billion for the six months to February 28, 2026, up 12.7% year on year, but operating profit slipped 4.3% to ¥4.9 billion and profit attributable to owners of parent fell 10.3% to &#...
JINS HOLDINGS Sets Interim Dividend at ¥47, Affirms 30% Payout Policy
Apr 10, 2026
JINS HOLDINGS Inc. has approved an interim dividend of ¥47 per share for the fiscal year ending August 31, 2026, with a record date of February 28, 2026 and a total payout of ¥1,111 million funded from retained earnings. The interim divi...
JINS Boosts March Sales and Opens First Global Flagship in Ginza
Apr 6, 2026
JINS HOLDINGS reported that in March 2026, sales across all Japan eyewear stores rose 11.0% year on year, with existing store sales up 7.6%. Growth was driven by higher spending per customer, supported by ongoing promotional campaigns, enhanced in...
JINS HOLDINGS Posts Solid February Sales Growth as Store Network Expands in Japan
Mar 5, 2026
JINS HOLDINGS reported that in February 2026, sales at all its eyewear stores in Japan rose 9.4% year on year, while existing store sales increased 6.7%. Despite reduced customer traffic due to snowfall and other adverse weather, higher average sp...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.